guidelines:
  1: Tisdale_Risk_Score_guideline.v1
test_cases:
- id: score>11
  input:
    1:
      gt0003|Age ≥68 years: 1|local::at0006|Yes|
      gt0004|Sex: 1|local::at0009|Female|
      gt0005|Patient on loop diuretic: 1|local::at0012|Yes|
      gt0006|Potassium ≤3.5 mEq/L: 2|local::at0015|Yes|
      gt0007|Admission QTc ≥450 msec: 2|local::at0018|Yes|
      gt0008|Being admitted for acute myocardial infarction: 2|local::at0021|Yes|
      gt0009|Being admitted for sepsis: 3|local::at0024|Yes|
      gt0010|Being admitted for heart failure: 3|local::at0027|Yes|
      gt0011|Number of QTc-prolonging drugs given: 6|local::at0031|≥2 QTc-prolonging drugs|
      gt0013|Is this a COVID-19 patient?: local::at0036|Confirmed negative|
  expected_output:
    1:
      gt0016|Recommendation: local::at0045|Consider consultation with pharmacist, adjusting risk factors as much as possible, and using alternative medications if possible. EKG should be repeated after 5 half-lives of QT-prolonging drugs given to evaluate QTc. |
      gt0015|Risk for QT prolongation: local::at0042|High risk for QT prolongation|
      gt0014|Tisdale Risk Score for QTc: 21
- id: score 11
  input:
    1:
      gt0003|Age ≥68 years: 1|local::at0006|Yes|
      gt0004|Sex: 1|local::at0009|Female|
      gt0005|Patient on loop diuretic: 0|local::at0011|No|
      gt0006|Potassium ≤3.5 mEq/L: 2|local::at0015|Yes|
      gt0007|Admission QTc ≥450 msec: 2|local::at0018|Yes|
      gt0008|Being admitted for acute myocardial infarction: 2|local::at0021|Yes|
      gt0009|Being admitted for sepsis: 3|local::at0024|Yes|
      gt0010|Being admitted for heart failure: 0|local::at0026|No|
      gt0011|Number of QTc-prolonging drugs given: 0|local::at0029|No|
      gt0013|Is this a COVID-19 patient?: local::at0036|Confirmed negative|
  expected_output:
    1:
      gt0016|Recommendation: local::at0045|Consider consultation with pharmacist, adjusting risk factors as much as possible, and using alternative medications if possible. EKG should be repeated after 5 half-lives of QT-prolonging drugs given to evaluate QTc. |
      gt0015|Risk for QT prolongation: local::at0042|High risk for QT prolongation|
      gt0014|Tisdale Risk Score for QTc: 11
- id: score >7
  input:
    1:
      gt0003|Age ≥68 years: 1|local::at0006|Yes|
      gt0004|Sex: 1|local::at0009|Female|
      gt0005|Patient on loop diuretic: 1|local::at0012|Yes|
      gt0006|Potassium ≤3.5 mEq/L: 2|local::at0015|Yes|
      gt0007|Admission QTc ≥450 msec: 2|local::at0018|Yes|
      gt0008|Being admitted for acute myocardial infarction: 0|local::at0020|No|
      gt0009|Being admitted for sepsis: 0|local::at0023|No|
      gt0010|Being admitted for heart failure: 0|local::at0026|No|
      gt0011|Number of QTc-prolonging drugs given: 0|local::at0029|No|
      gt0013|Is this a COVID-19 patient?: local::at0036|Confirmed negative|
  expected_output:
    1:
      gt0016|Recommendation: local::at0044|Consider consultation with pharmacist, adjusting risk factors as much as possible. EKG should be repeated after 5 half-lives of QT-prolonging drugs given to evaluate QTc. |
      gt0015|Risk for QT prolongation: local::at0041|Moderate risk for QT prolongation|
      gt0014|Tisdale Risk Score for QTc: 7
- id: score =6
  input:
    1:
      gt0003|Age ≥68 years: 1|local::at0006|Yes|
      gt0004|Sex: 1|local::at0009|Female|
      gt0005|Patient on loop diuretic: 0|local::at0011|No|
      gt0006|Potassium ≤3.5 mEq/L: 2|local::at0015|Yes|
      gt0007|Admission QTc ≥450 msec: 2|local::at0018|Yes|
      gt0008|Being admitted for acute myocardial infarction: 0|local::at0020|No|
      gt0009|Being admitted for sepsis: 0|local::at0023|No|
      gt0010|Being admitted for heart failure: 0|local::at0026|No|
      gt0011|Number of QTc-prolonging drugs given: 0|local::at0029|No|
      gt0013|Is this a COVID-19 patient?: local::at0036|Confirmed negative|
  expected_output:
    1:
      gt0016|Recommendation: local::at0043|Always consider that higher risk may develop depending on clinical course and drug interactions and pharmacokinetics.|
      gt0015|Risk for QT prolongation: local::at0040|Low risk for QT prolongation|
      gt0014|Tisdale Risk Score for QTc: 6
- id: score <6
  input:
    1:
      gt0003|Age ≥68 years: 1|local::at0006|Yes|
      gt0004|Sex: 1|local::at0009|Female|
      gt0005|Patient on loop diuretic: 0|local::at0011|No|
      gt0006|Potassium ≤3.5 mEq/L: 0|local::at0014|No|
      gt0007|Admission QTc ≥450 msec: 2|local::at0018|Yes|
      gt0008|Being admitted for acute myocardial infarction: 0|local::at0020|No|
      gt0009|Being admitted for sepsis: 0|local::at0023|No|
      gt0010|Being admitted for heart failure: 0|local::at0026|No|
      gt0011|Number of QTc-prolonging drugs given: 0|local::at0029|No|
      gt0013|Is this a COVID-19 patient?: local::at0036|Confirmed negative|
  expected_output:
    1:
      gt0016|Recommendation: local::at0043|Always consider that higher risk may develop depending on clinical course and drug interactions and pharmacokinetics.|
      gt0015|Risk for QT prolongation: local::at0040|Low risk for QT prolongation|
      gt0014|Tisdale Risk Score for QTc: 4
